Table 1.
Baseline demographic and laboratory data of the studied patients
| Variables | Number (300) | % | |
|---|---|---|---|
| Age (years) | Mean±SD | 49.73±10.97 | |
| Sex | Male | 178 | 59.33 |
| Female | 122 | 40.67 | |
| Liver status | Non-cirrhotic | 203 | 67.67 |
| Cirrhotic | 97 | 32.33 | |
| Child–Pugh score | Child A | 77 | 79.38 |
| (N:97) | Child B | 20 | 20.62 |
| History of treatment | Treatment-naïve | 238 | 79.33 |
| Treatment-experienced | 62 | 20.67 | |
| History of diabetes mellitus | Non-diabetic | 228 | 76 |
| Diabetic | 72 | 24 | |
| Hb (g/dL) | Mean±SD | 13.26±1.71 | |
| WBC (×103)/mm3 | Mean±SD | 6.44±2.15 | |
| Platelet (×103)/mm3 | Mean±SD | 207.27±92.88 | |
| ALT (IU/L) | Mean±SD | 57.39±42.93 | |
| AST (IU/L) | Mean±SD | 57.54±32.93 | |
| Serum bilirubin (mg/dL) | Mean±SD | 1.36±0.40 | |
| Serum albumin (mg/dL) | Mean±SD | 4.12±0.54 | |
| INR | Mean±SD | 1.51±0.22 |
Abbreviations: ALT, alanine transaminase; AST, aspartate transaminase; Hb, hemoglobin; INR, international normalized ratio; WBC, white blood cells.